Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:
Valeant Pharmaceuticals (VRX) : "No, please don't buy it. The debt situation is hideous."
Alder Biopharmaceuticals (ALDR) : "They've been smacking it around, I want to do more research."
Meanwhile, on Real Money, Peter Tchir said the jobs report wasn't all that bad, and he anticipated Treasury yields would be buoyed. He was right. Get more of this kind of insight with a free trial subscription to Real Money.
Cramer and the AAP team say Magellan Midstream Partners (MMP - Get Report) is getting another leg up. Find out what they're telling their investment club members. Get a free trial subscription to Action Alerts PLUS.
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To read a full recap of this episode of "Mad Money," click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.